Optimi Health Corp. filed a Form F-1 registration statement for an initial public offering on 2025-09-05. It has amended it 8 times. It filed its final prospectus on 2026-05-20. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our common shares are listed on Nasdaq under the symbol “OPTH” and in Canada on the Canadian Securities Exchange (the “CSE”) under the symbol “OPTI” and in Germany on the Frankfurt Stock Exchange (the “FSE”) under the symbol “8BN”.From the F-1 filed 2026-08-17
Shares offered
We are offering 2,500,000 units (“Units”), with each Unit consisting of (i) one common share and (ii) one warrant (“Common Warrant”).From the F-1/A filed 2026-04-16
Use of proceeds
We currently intend to use the net proceeds we receive from this offering for scaling production and distribution of our products in our current markets, additional market expansion to Israel and the United States and sales growth and general working capital and other operating expenses.From the 424B4 filed 2026-05-20
Net loss or income
During the nine months ended June 30, 2026 and the fiscal year ended September 30, 2025, we incurred a net loss of C$5,552,091 (US$3,147,661) and C$3,712,031 (US$2,665,349), respectively, and have not yet achieved profitable operations.From the F-1 filed 2026-08-17
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-09-05 | Registration statement filed (foreign issuer) | F-1 |
| 2026-02-17 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-03-13 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-03-24 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-04-16 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-04-21 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-04-21 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-04-23 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-05-19 | Registration statement amended (foreign issuer) | F-1/A |
| 2026-05-20 | Final prospectus filed: the offering is priced | 424B4 |
| 2026-08-17 | Registration statement filed (foreign issuer) | F-1 |
Tools for this story
Each opens in a new tab, filled in for Optimi Health Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.